147 related articles for article (PubMed ID: 30430783)
21. [Clinical features and treatment outcomes of peripheral T-cell lymphoma, unspecified: a report of 78 cases].
Yu YX; Shi YK; He XH; Zhou LQ; Zhou SY; Dong M; Feng FY; Sun Y
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2714-6. PubMed ID: 18167252
[TBL] [Abstract][Full Text] [Related]
22. FDG PET for Evaluation of Bone Marrow Status in T-Cell Lymphoma.
Koh Y; Lee JM; Woo GU; Paeng JC; Youk J; Yoon SS; Kim I; Kang KW
Clin Nucl Med; 2019 Jan; 44(1):4-10. PubMed ID: 30371574
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of concordant and discordant cytomorphology of bone marrow involvement in patients with diffuse, large, B-cell lymphoma treated with R-CHOP.
Shim H; Oh JI; Park SH; Jang S; Park CJ; Huh J; Suh C; Chi HS
J Clin Pathol; 2013 May; 66(5):420-5. PubMed ID: 23610041
[TBL] [Abstract][Full Text] [Related]
24. A lower ALC/AMC ratio is associated with poor prognosis of peripheral T-cell lymphoma-not otherwise specified.
Li Q; Gao S; Ma J; Liu S; Yue Y; Chen L; Li H; Wang X; Li D; Cao Z; Zhao Z; Wang X; Yu Y; Zhang Y; Wang Y
Leuk Res; 2018 Oct; 73():5-11. PubMed ID: 30172956
[TBL] [Abstract][Full Text] [Related]
25. Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP.
Sehn LH; Scott DW; Chhanabhai M; Berry B; Ruskova A; Berkahn L; Connors JM; Gascoyne RD
J Clin Oncol; 2011 Apr; 29(11):1452-7. PubMed ID: 21383296
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological analysis of immunohistochemical expression of retinoic acid-related orphan receptor-γt in peripheral T-cell lymphoma, not otherwise specified.
Yanagida E; Miyoshi H; Kawamoto K; Nakashima K; Matsuda K; Yamada K; Muto R; Nagafuji K; Seto M; Ohshima K
Hum Pathol; 2018 Sep; 79():86-92. PubMed ID: 29775622
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of Clinical Characteristics and Prognosis of 46 Elderly Patients with Peripheral T Cell Lymphoma (PTCL)].
Wang TT; Zhang ZG; Yang HL; Li Q; Xia B; Zhao HF; Yu Y; Wang XF; Wang YF; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):438-43. PubMed ID: 27151006
[TBL] [Abstract][Full Text] [Related]
28. [Small cell variant of peripheral T-cell lymphoma, not otherwise specified: a clinicopathologic and immunophenotypic analysis].
Li YL; Liu WP; Tang Y; Zhao S; Zuo Z; Yang YH; Yang QP; Luo TY
Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):323-8. PubMed ID: 19575875
[TBL] [Abstract][Full Text] [Related]
29. CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin.
Shibata Y; Hara T; Kasahara S; Yamada T; Sawada M; Mabuchi R; Matsumoto T; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Kanemura N; Kito Y; Goto N; Miyazaki T; Takami T; Takeuchi T; Shimizu M; Tsurumi H
Hematol Oncol; 2017 Jun; 35(2):163-171. PubMed ID: 26449182
[TBL] [Abstract][Full Text] [Related]
30. Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network.
Federico M; Bellei M; Marcheselli L; Schwartz M; Manni M; Tarantino V; Pileri S; Ko YH; Cabrera ME; Horwitz S; Kim WS; Shustov A; Foss FM; Nagler A; Carson K; Pinter-Brown LC; Montoto S; Spina M; Feldman TA; Lechowicz MJ; Smith SM; Lansigan F; Gabus R; Vose JM; Advani RH;
Br J Haematol; 2018 Jun; 181(6):760-769. PubMed ID: 29672827
[TBL] [Abstract][Full Text] [Related]
31. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ
Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of T-cell receptor gamma rearrangement in peripheral blood or bone marrow of patients with peripheral T-cell lymphomas.
Schützinger C; Esterbauer H; Hron G; Skrabs C; Uffmann M; Raderer M; Hauswirth A; Mannhalter C; Dieckmann K; Wagner O; Formanek M; Stift A; Friedl J; Gaiger A; Chott A; Jäger U
Leuk Lymphoma; 2008 Feb; 49(2):237-46. PubMed ID: 18231909
[TBL] [Abstract][Full Text] [Related]
33. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project.
Weisenburger DD; Savage KJ; Harris NL; Gascoyne RD; Jaffe ES; MacLennan KA; Rüdiger T; Pileri S; Nakamura S; Nathwani B; Campo E; Berger F; Coiffier B; Kim WS; Holte H; Federico M; Au WY; Tobinai K; Armitage JO; Vose JM;
Blood; 2011 Mar; 117(12):3402-8. PubMed ID: 21270441
[TBL] [Abstract][Full Text] [Related]
34. Outcomes following front-line chemotherapy in peripheral T-cell lymphoma: 10-year experience at The Royal Marsden and The Christie Hospital.
Gleeson M; Peckitt C; Cunningham D; Gibb A; Hawkes EA; Back M; Yasar B; Foley K; Lee R; Dash J; Johnson H; O'Hara C; Wotherspoon A; Attygalle A; Menasce L; Shenjere P; Potter M; Ethell ME; Dearden C; Radford J; Chau I; Linton K
Leuk Lymphoma; 2018 Jul; 59(7):1586-1595. PubMed ID: 29119842
[TBL] [Abstract][Full Text] [Related]
35. Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors.
Mak V; Hamm J; Chhanabhai M; Shenkier T; Klasa R; Sehn LH; Villa D; Gascoyne RD; Connors JM; Savage KJ
J Clin Oncol; 2013 Jun; 31(16):1970-6. PubMed ID: 23610113
[TBL] [Abstract][Full Text] [Related]
36. Clinical analysis and prognostic significance of lymphoma-associated hemophagocytosis in peripheral T cell lymphoma.
Xie W; Hu K; Xu F; Zhou D; He J; Shi J; Luo Y; Zhu J; Zhang J; Lin M; Ye X; Huang H; Cai Z
Ann Hematol; 2013 Apr; 92(4):481-6. PubMed ID: 23238896
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of bone marrow infiltration detected by PET-CT in newly diagnosed diffuse large B cell lymphoma.
Liang JH; Sun J; Wang L; Fan L; Chen YY; Qu XY; Li TN; Li JY; Xu W
Oncotarget; 2016 Apr; 7(14):19072-80. PubMed ID: 26919239
[TBL] [Abstract][Full Text] [Related]
38. Angioimmunoblastic T-cell lymphoma: a prognostic model from a retrospective study.
Hong H; Fang X; Wang Z; Huang H; Lam ST; Li F; Peng C; Tian Y; Lin S; Lin T
Leuk Lymphoma; 2018 Dec; 59(12):2911-2916. PubMed ID: 29909754
[TBL] [Abstract][Full Text] [Related]
39. Prognostic markers in peripheral T-cell lymphoma.
Piccaluga PP; Agostinelli C; Gazzola A; Mannu C; Bacci F; Sabattini E; Pileri SA
Curr Hematol Malig Rep; 2010 Oct; 5(4):222-8. PubMed ID: 20690003
[TBL] [Abstract][Full Text] [Related]
40. [CD20-positive peripheral T-cell lymphoma, not otherwise specified].
Arai H; Maki K; Tadokoro J; Handa T; Nakamura Y; Tsurumi S; Sasaki K; Mitani K
Rinsho Ketsueki; 2012 Jul; 53(7):705-9. PubMed ID: 22975773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
